Last update 12 Jul 2026

LRRK2 Inhibitors 44(Vernalis)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
LRRK2
Action
inhibitors
Mechanism
LRRK2 inhibitors(Leucine-rich repeat serine/threonine-protein kinase 2 inhibitors)
Therapeutic Areas
Nervous System DiseasesOther DiseasesEndocrinology and Metabolic Disease
Active Indication
CataplexyParkinson Disease
Inactive Indication-
Originator Organization
Vernalis (R&D) Ltd.
Active Organization
H. Lundbeck A/SH. Lundbeck A/SVernalis (R&D) Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with LRRK2 Inhibitors 44(Vernalis)
CTIS2025-522652-58-01
/ RecruitingPhase 1
A trial to test the safety and tolerability of Lu AH70212 and Lu AH69593 in healthy adults.
100 Clinical Results associated with LRRK2 Inhibitors 44(Vernalis)
Login to view more data
100 Translational Medicine associated with LRRK2 Inhibitors 44(Vernalis)
Login to view more data
100 Patents (Medical) associated with LRRK2 Inhibitors 44(Vernalis)
Login to view more data
100 Deals associated with LRRK2 Inhibitors 44(Vernalis)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CataplexyPhase 1
France
H. Lundbeck A/SH. Lundbeck A/S
19 Feb 2026
Parkinson DiseasePreclinical
Denmark
H. Lundbeck A/SH. Lundbeck A/S
29 Jun 2021
Parkinson DiseasePreclinical
United Kingdom
Vernalis (R&D) Ltd.
29 Jun 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free